Superior vena cava syndrome overview

Revision as of 15:40, 23 January 2013 by Hardik Patel (talk | contribs)
Jump to navigation Jump to search

Superior Vena Cava Syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Superior Vena Cava Syndrome from Other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Radiation Therapy

Surgery

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Superior vena cava syndrome overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Superior vena cava syndrome overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Superior vena cava syndrome overview

CDC on Superior vena cava syndrome overview

Superior vena cava syndrome overview in the news

Blogs on Superior vena cava syndrome overview

Directions to Hospitals Treating Superior vena cava syndrome

Risk calculators and risk factors for Superior vena cava syndrome overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Superior vena cava syndrome (SVCS) is an array of symptoms caused by the impairment of blood flow through the superior vena cava (SVC) to the right atrium. Symptoms that prompt suspicion of this syndrome include dyspnea, coughing, and swelling of the face, neck, upper trunk, and extremities. In rare instances, patients may complain of hoarseness, chest pain, dysphagia, and hemoptysis. Physical signs that may be noted on presentation are neck vein distention, thoracic vein distention, edema of the face or upper extremities, plethora, and tachypnea. Rarely, cyanosis, Horner syndrome, and a paralyzed vocal cord may also be present.

Historical Perspective

The Scottish obstetrician and anatomist, William Hunter, first described the superior vena cava syndrome in 1757, noting it as a complication of a syphilitic aortic aneurysm. In the past, it was a medical emergency and empiric radiation was given to shrink the tumor. With the advent of better medical therapy for some lung cancers and lymphoma and the low morbidity associated with diagnostic procedures, this approach has fallen out of favor.

Pathophysiology

The superior vena cava (SVC) is the major blood vessel for drainage of venous blood from the head, neck, upper extremities, and upper thorax to the heart. Obstruction of the superior vena cava (SVC) may be caused by neoplastic invasion of the venous wall associated with intravascular thrombosis, enlarged nodes, enlarged ascending aorta, or more simply, by extrinsic pressure of a tumor mass against the thin-walled superior vena cava (SVC) which leads to the development of SVC syndrome.

Causes

Superior vena cava syndrome may be caused by obstruction of the superior vena cava (SVC) by neoplastic invasion of the venous wall associated with intravascular thrombosis, enlarged nodes, enlarged ascending aorta, or more simply, by extrinsic pressure of a tumor mass against the thin-walled superior vena cava (SVC).

Differentiating Superior Vena Cava Syndrome from other Diseases

Superior vena cava syndrome should be differentiated from other causes of dyspnea and jugular venous distention, such as, cardiac tamponade, chronic obstructive pulmonary disease, mediastinitis, pneumonia, acute respiratory distress syndrome, syphilis, and tuberculosis.

Epidemiology and Demographics

Most SVC syndromes in the present day are related to malignancy. An underlying malignancy is found in approximately 90% of patients.

References

Template:WH Template:WS